知识产权
中成药
范围(计算机科学)
中国
药方
授权
专利申请
业务
中医药
传统医学
法律与经济学
医学
法理学
替代医学
法学
政治学
药理学
计算机科学
经济
计算机安全
病理
程序设计语言
作者
Xingang Feng,Lijun Fan,Chenghua Li,Zhiguo Ma
出处
期刊:Traditional Chinese Medicine
[Hans Publishers]
日期:2019-10-30
卷期号:41 (10): 1039-1042
标识
DOI:10.3760/cma.j.issn.1673-4246.2019.10.001
摘要
Through the analysis of patent jurisprudence, it is proved that the Classical Prescription of Traditional Chinese Medicine (CPTCM) belongs to the scope of existing technology in the Law of Patent, and has lost the foundation of obtaining patent rights. Taking Japan's CPTCM as an example, based on the analysis of the administration of CPTCM and patent applications related to CPTCM in Japan, it is proved that CPTCM can not obtain patent authorization in Japan. Through the comparison of patent in China, the United States, Europe and worldwide region, it is proved that China is still the main source of patent applications for Traditional Chinese Medicine. At the end of the article, the author puts forward the suggestion of active protection. It is believed that we should abandon the concept of patent-only protection and improve the influence of Traditional Chinese Medicine in worldwide from the aspects of industrial development, promotion ofits application, and intellectual property protection.
Key words:
Traditional Chinese medicine and pharmacy; Classical prescription; Medicine, kampo; Patent analysis; Intellectual property protection
科研通智能强力驱动
Strongly Powered by AbleSci AI